Project Details
Oncogenic mutations in (benign) skin tumors and nevi: relevance, mechanisms and therapeutic perspectives
Applicant
Professor Dr. Mark-Jürgen Berneburg, since 11/2017
Subject Area
Dermatology
Term
from 2014 to 2018
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 263643178
The first objective of this study is the identification of oncogenic mutation patterns and pathways, which are critically involved in the pathogenesis of benign and malignant sebaceous tumors. The obtained genetic, immunohistochemical and functional data will allow to specifically characterize and contrast benign with malignant sebaceous tumors. A clearer understanding of what makes sebaceous tumors benign or malignant will help to identify starting points for targeted molecular therapies of these tumors. After HRAS and KRAS mutations have been shown to be causally involved in the pathogenesis of sebaceous nevi, further organoid epidermal nevi (in particular nevus comedonicus) shall be screened for oncogenic mutations as well. Knowledge of the genetic background of organoid epidermal nevi like the nevus comedonicus is valuable, as it allows to draw inferences about the pathogenesis of associated tumors. Furthermore, as nevus comedonicus shares certain histological characteristics with acne comedonica, the obtained results could contribute to a better unterstanding of the latter disease as well.
DFG Programme
Research Grants
Participating Persons
Professor Dr. Jürgen Bauer; Professor Dr. Christian Hafner; Professor Dr. Peter Kind; Professor Dr. Wulf Schneider; Professor Dr. Christos C. Zouboulis
Ehemaliger Antragsteller
Dr. Leopold Größer, until 10/2017